MedPath

ETOP IBCSG Partners Foundation

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2016-09-16
Lead Sponsor
ETOP IBCSG Partners Foundation
Target Recruit Count
1086
Registration Number
NCT00022516
Locations
🇦🇺

Christchurch Hospital, Christchurch, Australia

🇧🇪

CHU Liege - Domaine Universitaire du Sart Tilman, Liege, Belgium

🇮🇹

Ospedale Sant' Eugenio, Rome, Italy

and more 33 locations
© Copyright 2025. All Rights Reserved by MedPath